Total Payments
$6,440
2024 Payments
$1,133
Companies
21
Transactions
251
Medicare Patients
250
Medicare Billing
$70,819
Payment Breakdown by Category
Food & Beverage$6,429 (99.8%)
Education$10.82 (0.2%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,429 | 249 | 99.8% |
| Education | $10.82 | 2 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $3,127 | 134 | $0 (2024) |
| PFIZER INC. | $625.14 | 20 | $0 (2024) |
| Biohaven Pharmaceutical Holding Company Ltd. | $580.35 | 14 | $0 (2022) |
| Biohaven Pharmaceuticals, Inc. | $444.52 | 9 | $0 (2021) |
| Teva Pharmaceuticals USA, Inc. | $404.09 | 16 | $0 (2024) |
| Allergan, Inc. | $298.57 | 21 | $0 (2022) |
| Lilly USA, LLC | $257.05 | 7 | $0 (2024) |
| Biogen, Inc. | $127.06 | 5 | $0 (2023) |
| Amgen Inc. | $116.14 | 6 | $0 (2023) |
| SCILEX PHARMACEUTICALS INC. | $83.63 | 4 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,133 | 58 | ABBVIE INC. ($590.09) |
| 2023 | $1,536 | 63 | ABBVIE INC. ($1,017) |
| 2022 | $2,083 | 65 | ABBVIE INC. ($886.57) |
| 2021 | $1,441 | 56 | AbbVie Inc. ($633.56) |
| 2020 | $147.56 | 7 | Amgen Inc. ($59.62) |
| 2019 | $99.15 | 2 | Lundbeck LLC ($64.17) |
All Payment Transactions
251 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | ABBVIE INC. | BOTOX (Biological), QULIPTA | Food and Beverage | In-kind items and services | $21.14 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 12/11/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $27.13 | General |
| Category: PAIN | ||||||
| 11/06/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $28.64 | General |
| Category: PAIN | ||||||
| 11/01/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $24.85 | General |
| Category: NEUROSCIENCE | ||||||
| 10/30/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $13.38 | General |
| Category: NEUROSCIENCE | ||||||
| 10/17/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $21.32 | General |
| Category: NEUROSCIENCE | ||||||
| 10/17/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $21.22 | General |
| Category: NEUROSCIENCE | ||||||
| 10/16/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $16.46 | General |
| Category: Central Nervous System | ||||||
| 10/08/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $4.89 | General |
| Category: NEUROSCIENCE | ||||||
| 10/02/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $20.64 | General |
| Category: NEUROSCIENCE | ||||||
| 09/30/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $15.22 | General |
| Category: Central Nervous System | ||||||
| 09/25/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $26.31 | General |
| Category: PAIN | ||||||
| 09/17/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $22.92 | General |
| Category: NEUROSCIENCE | ||||||
| 09/13/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $21.96 | General |
| Category: NEUROSCIENCE | ||||||
| 09/09/2024 | SCILEX PHARMACEUTICALS INC. | ZTLido (Drug) | Food and Beverage | In-kind items and services | $18.10 | General |
| Category: Analgesic | ||||||
| 08/28/2024 | Takeda Pharmaceuticals U.S.A., Inc. | HYQVIA (Biological) | Food and Beverage | In-kind items and services | $18.84 | General |
| Category: IMMUNOLOGY | ||||||
| 08/26/2024 | ABBVIE INC. | BOTOX (Biological), QULIPTA | Food and Beverage | In-kind items and services | $7.11 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 08/16/2024 | Lilly USA, LLC | EMGALITY (Drug) | Food and Beverage | In-kind items and services | $21.09 | General |
| Category: Neuroscience | ||||||
| 08/14/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $24.41 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 08/14/2024 | Kedrion Biopharma, Inc. | Albuked (Biological), KOATE, GAMMAKED | Food and Beverage | Cash or cash equivalent | $17.23 | General |
| Category: Critical Care | ||||||
| 08/08/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $25.39 | General |
| Category: NEUROSCIENCE | ||||||
| 08/02/2024 | ABBVIE INC. | BOTOX (Biological), QULIPTA | Food and Beverage | In-kind items and services | $27.67 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 07/26/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $17.17 | General |
| Category: NEUROLOGY | ||||||
| 07/26/2024 | ABBVIE INC. | QULIPTA (Drug), BOTOX | Food and Beverage | In-kind items and services | $2.71 | General |
| Category: NEUROSCIENCE | ||||||
| 07/25/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $9.54 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 90 | 6,577 | $180,060 | $44,740 |
| 2022 | 4 | 79 | 105 | $41,450 | $13,055 |
| 2021 | 4 | 81 | 96 | $42,200 | $13,024 |
Total Patients
250
Total Services
6,778
Medicare Billing
$70,819
Procedure Codes
13
All Medicare Procedures & Services
13 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2023 | 14 | 6,470 | $129,400 | $32,114 | 24.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 31 | 43 | $13,160 | $4,180 | 31.8% |
| 64615 | Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | Office | 2023 | 15 | 32 | $23,350 | $4,044 | 17.3% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 17 | 18 | $8,190 | $2,469 | 30.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 13 | 14 | $5,960 | $1,933 | 32.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 36 | 61 | $18,760 | $5,985 | 31.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 15 | 15 | $8,430 | $2,604 | 30.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 14 | 15 | $6,325 | $2,349 | 37.1% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 14 | 14 | $7,935 | $2,117 | 26.7% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 32 | 32 | $18,400 | $5,401 | 29.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 22 | 33 | $10,230 | $3,454 | 33.8% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 15 | 15 | $8,850 | $2,863 | 32.4% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 12 | 16 | $4,720 | $1,306 | 27.7% |
About Dr. Sandhya Mehla, MBBS
Dr. Sandhya Mehla, MBBS is a Pain Medicine healthcare provider based in West Hartford, Connecticut. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/15/2014. The National Provider Identifier (NPI) number assigned to this provider is 1215356399.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sandhya Mehla, MBBS has received a total of $6,440 in payments from pharmaceutical and medical device companies, with $1,133 received in 2024. These payments were reported across 251 transactions from 21 companies. The most common payment nature is "Food and Beverage" ($6,429).
As a Medicare-enrolled provider, Mehla has provided services to 250 Medicare beneficiaries, totaling 6,778 services with total Medicare billing of $70,819. Data is available for 3 years (2021–2023), covering 13 distinct procedure/service records.
Ad
Practice Information
- Specialty Pain Medicine
- Other Specialties Neurology, Vascular Neurology
- Location West Hartford, CT
- Active Since 04/15/2014
- Last Updated 07/23/2024
- Taxonomy Code 2084P2900X
- Entity Type Individual
- NPI Number 1215356399
Products in Payments
- UBRELVY (Drug) $1,934
- NURTEC ODT (Drug) $1,500
- BOTOX (Biological) $967.37
- QULIPTA (Drug) $524.74
- EMGALITY (Drug) $232.59
- AJOVY (Biological) $215.90
- Aimovig (Biological) $116.14
- TYSABRI (Biological) $102.08
- Austedo XR (Drug) $98.83
- ZTLido (Drug) $83.63
- Trudhesa (Drug) $82.99
- COMIRNATY (Biological) $81.21
- AUSTEDO (Drug) $54.38
- Hizentra (Biological) $49.01
- AJOVY (Drug) $34.98
- ZEMBRACE SYMTOUCH (Drug) $26.22
- OXTELLAR XR (Drug) $25.60
- GELFOAM (Device) $25.51
- PLEGRIDY (Biological) $24.98
- AMYVID (Drug) $24.46
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.